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We amplified by polymerase chain reaction the heavy and light chain antibody genes of two mouse hybridomas secreting
neutralizing monoclonal antibodies (MAbs) to the G1 or G2 envelope proteins of Hantaan virus, cloned them into the
phagemid vector pComb3, and expressed them in bacteria to yield Fab fragments. Expressed Fab fragments had the same
antigenic specificities for Hantaan and Seoul viruses as the complete parent MAbs and were able to neutralize Hantaan
virus in plaque-reduction neutralization assays. The authentic MAb to G2 (HCO2) could passively protect hamsters from
challenge with Hantaan virus when neutralizing antibody titers of at least 1:10 were detected in the animals’ sera just prior
to challenge. In contrast, although 1:10 neutralization titers were also detected in hamsters receiving passively transferred,
Escherichia coli-expressed HCO2 Fab, these animals were not protected from infection with Hantaan virus. Similarly, passive
transfer of the HCO2 MAb on Days 1 through 4 after infection prevented antigen deposition in hamster lungs and kidneys
but passive transfer of the recombinant HCO2 Fab did not. The results suggest that although neutralization by IgG antibodies
correlates with protection in hamsters, the same may not be true for neutralizing Fab fragments. q 1996 Academic Press, Inc.
INTRODUCTION et al., 1987; Avsic-Zupanc et al., 1994; Lee and Dalrymple,
1989). Intervention with therapeutic neutralizing human
Viruses in the Hantavirus genus, family Bunyaviridae, monoclonal antibodies (MAbs) might, therefore, prove use-
are known to cause two serious and often fatal diseases: ful for shortening the viremic period of HFRS. Neutralizing
hemorrhagic fever with renal syndrome (HFRS) and han- antibodies were also found to passively protect animals
tavirus pulmonary syndrome. Approximately 200,000 hos- from challenge with HTN or SEO viruses (Antoniadis et al.,
pitalized cases of HFRS occur annually, about half of 1989; Schmaljohn et al., 1990; Zhang et al., 1989; Arikawa
them in China. Hantaviruses are carried by specific ro- et al., 1992); thus, neutralizing human MAbs might prove
dent hosts and are transmitted as infectious aerosols of useful for postexposure prophylaxis.
urine, feces, or saliva (reviewed in Lee and Dalrymple, Methods have recently been developed for generating
1989). At least four hantaviruses cause HFRS: Hantaan combinatorial human antibody libraries by expressing
(HTN) virus, carried by Apodemus agrarius (striped field antibody genes obtained from immune individuals.
mice); Seoul (SEO) virus, carried by Rattus novegicus Phage display of antibody fragments has proven to be
(domestic rats); Dobrava virus carried by Apodemus flavi- a useful means for selecting antibodies of the desired
colis (yellow-necked mice); and Puumala virus, carried specificity and has resulted in the development of murine
by Clethrionomys glariolus (bank voles) (Lee et al., 1978, or human MAbs to a number of viruses including influ-
1982; Brummer-Korvenkontio et al., 1980; Avsic-Zupanc
enza virus, human immunodeficiency virus, rabies virus,
et al., 1992; Taller et al., 1993). Several hantavirus vac-
respiratory syncitial virus, and hepatitis B virus (Caton
cines are currently undergoing clinical trials, but no vac-
and Koprowski, 1990; Burton et al., 1991; Cheung et al.,
cine has yet been proven effective for preventing HFRS.
1992; Barbas et al., 1992; Zebedee et al., 1992). As a first
Therapeutic measures are generally limited to supportive
step toward developing human MAbs as a therapeutic
care, although the drug ribavirin improved disease out-
reagent for treatment of HFRS, we cloned and expressed
come in a trial performed in China (Huggins et al., 1991).
in bacteria the heavy and light chain antibody genes from
Immunotherapy for treatment or prophylaxis of hantaviral
two mouse hybridomas secreting HTN virus G1- or G2-infections of humans has not been widely studied. HFRS
specific MAbs and evaluated the resultant Fab fragmentspatients remain viremic during the acute phase of disease
for their ability to recognize viral antigens and to neutral-as evidenced by the isolation of viruses from blood col-
ize HTN virus in cell culture. We also compared the abilitylected during this time (Schmaljohn et al., 1988; Antoniades
of the anti-G2 Fab to that of the parent MAb for the
ability to passively protect hamsters from challenge with
virulent HTN virus.1 To whom reprint requests should be addressed.
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MATERIALS AND METHODS al., 1989) to the G1 and G2 proteins of HTN virus which
were conjugated with horseradish peroxidase (HRP) by
Virus and cells a method described previously (Harlow and Lane, 1988).
After selection, the phagemids were reisolated, digestedHTN (76-118) and SEO (SR-11) viruses were propa-
with SpeI and NheI to remove the gene III fragment,gated in Vero–E6 cells (ATCC C1008, CRL1586), concen-
and religated to yield a phagemid capable of expressingtrated by precipitation with polyethylene glycol, and puri-
soluble Fab fragments. These clones, designated 2D5fied by sucrose gradient sedimentation as previously de-
Fab and HCO2 Fab, were grown in super broth mediumscribed (Schmaljohn et al., 1983). The mouse hybridoma
[30 g tryptone, 20 g yeast extract, 10 g MOPS buffer percell lines secreting neutralizing MAb to G1 (2D5) and G2
liter, pH 7.0 (containing 50 mg ampicillin/ml)] until an(HCO2) were described previously (Arikawa et al., 1989).
OD600 of 0.2 to 0.4 was achieved. Then 1 mM IPTG was
Cloning of heavy and light chain antibody genes added and the culture was grown overnight at 307 or at
room temperature. Cells were pelleted by centrifugation
Total cellular RNA was isolated from pelleted hybrid- and lysed by three cycles of freezing at0707 and thawing
oma cells with Trizol reagent (Gibco BRL, Gaithersburg, at room temperature. Cell lysates were clarified by cen-
MD). cDNA was synthesized by using oligo(dT) primers trifugation at 12,000 to 14,000 rpm in a microcentrifuge
and reverse transcriptase (Boehringer Mannheim cDNA at 47 for 15 min and the resultant supernatants were
Synthesis kit, Indianapolis, IN) and was amplified by poly- filtered through 0.45-mm filters and applied to an affinity
merase chain reaction (PCR) with specific heavy and light column, which was prepared by covalently coupling puri-
chain primers of murine IgG. Forward primers used were fied anti-mouse IgG Fab antibodies (Sigma, St. Louis,
HC1 (5*-AGGTCCAGCTGCTCGAGTCTGG-3 *) and Vk (5*- MO) to protein G–Sepharose 4B (Sigma) with dimethylpi-
CCAGATGTGAGCTCGTGATGACCCAGTCTCCA-3 *), and melimidate, as described previously (Harlow and Lane,
reverse primers were IgG1 (5*-AGGCTTACTAGTACA- 1988). The Fab proteins were eluted with a buffer con-
ATCCCTGGGCACAAT-3 *), IgG2a/2b (5*-GATATCACT- sisting of 1.0 M glycogen–HCl (pH 2.7) and were neutral-
AGTGGGCCCGCTGGGCTC-3 *), and Ck2 (5*-GCGCCG- ized by adding 1 M Tris–HCl, pH 9.0. The eluted fractions
TCTAGAATTAACACTCATTCCTGTTGAA-3 *) (Kang et al., were concentrated by using Centricon-10 filters (Amicon,
1991). Thirty-five PCR cycles were performed, each con- Beverly, MA) and protein concentrations were deter-
sisting of 947 for 1 min, 527 for 1 min, and 727 for 2 min. mined with the BCA protein assay kit according to the
The resultant PCR products were gel-purified in agarose manufacturer’s directions (Pierce, Rockford, IL).
and extracted using Spin-X columns (Costar, Broadway/
Cambridge, MA). The heavy chain Fd and light chain Preparation and purification of IgG and Fab
genes were then successively cloned into the phagemid fragments
expression vector pComb3 (Barbas et al., 1991) using Complete IgG molecules of the neutralizing MAbs 2D5
XhoI/SpeI and SacI/XbaI sites, respectively. and HCO2, and a control nonneutralizing MAb to the
nucleocapsid protein of HTN virus, BDO1 (Ruo et al.,Escherichia coli expression and purification of soluble
1991), were purified from mouse ascitic fluids by usingFab fragments
an IgG purification kit, MAbTrap G (Pharmacia LKB Bio-
technology Inc., Piscataway, NJ). Fab fragments wereThe ligated pComb3 vector with heavy chain Fd and
light chain PCR DNAs was electroporated into competent prepared by using the Immuno Pure Fab Preparation kit
(Pierce, Rockford, IL). Briefly, the purified IgG describedXLI-Blue E. coli cells (Stratagene, La Jolla, CA) by using
a BRL Cell-Porator Electroporation system, with settings above was digested with agarose-immobilized papain at
377 for 5 hr, the crude digest was applied to an immobi-of 400 to 420 voltage charge, and a final delivery electric
pulse of 2.5 V (BRL Life Technologies, Inc., Gaithersburg, lized protein A column, and the Fab fragments were
eluted and concentrated. Twenty microliters each of theMD). After transformation, cells were streaked on LB/
ampicillin plates and the clones with both inserts were purified IgG, papain-derived, and recombinant Fabs (0.9–
1.0 mg/ml) were examined by SDS–polyacrylamide gelselected by colony screening by methods similar to those
published previously (Barbas et al., 1991). Briefly, bacte- electrophoresis (PAGE) in 12.5% acrylamide/DATD gels
as previously described (Schmaljohn et al., 1983). Gelsrial colonies were induced with isopropyl B-D-thiogalac-
topyrano-side (IPTG), and colonies were transferred to were fixed and then stained with 0.2% Coomasie brilliant
blue.nitrocellulose and treated with chloroform. The filters
were blocked with phosphate-buffered saline, pH 7.4,
Immunoprecipitation of Hantaan virus with thecontaining 3% bovine serum albumin (PBS–BSA). Filters
recombinant Fabswere incubated with purified HTN virus antigen diluted
in PBS–BSA, washed in PBS containing 0.1% Tween-20, Confluent monolayers of Vero–E6 cells in 25-cm2
flasks were infected with 1 ml of HTN virus (strain 76-and incubated with MAbs 11E10 and 6D4 (Arikawa et
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118, 1.91 106 PFU). At 24 hr postinfection, the cell culture described above and 100 ml of a 1:2000 dilution of HRP-
conjugated anti-mouse Fab (Sigma, St. Louis, MO) wasmedium was removed and replaced with cysteine- and
methionine-free Eagle’s minimal essential medium, added and incubated at 377 for 1 hr. After washing, 100
ml of ABTS peroxidase substrate (Kirkegard & Perry Labo-Earles’ salts, containing 2% FBS, and incubated for 1 hr at
377. Cells were radiolabeled with 200 mCi of [35S]Promix ratories, Gaithersburg, MD) was added and the plates
were incubated for 20 min at room temperature. Relative(Amersham, UK) per flask for 4 hr, after which they were
lysed on ice with 1 ml of a buffer composed of 10 mM binding avidity was defined as the amount of purified
Fabs (mg Fab protein) required to yield an absorbanceTris–HCl, pH 8.0, 1 mM EDTA, 0.5 M NaCl, 0.25 mg/ml
each aprotinin and a-2-macroglobulin, and 4% Zwitter- of 0.4–0.5 at 405 nm in a Bio-Lab ELISA reader.
gent 3-14 (Calbiochem– Behring, La Jolla, CA). Nuclei
Nucleotide sequence analysiswere removed by centrifugation. Radiolabeled HTN virus
proteins were immune-precipitated by mixing 100 ml of
Plasmid DNA was prepared by using the Qiagen mini-
cell lysate with 100 ml of the clarified bacterial lysates
prep kit (Qiagen, Charsworth, CA). Nucleotide sequences
containing recombinant Fabs. The mixture was incu-
of the variable regions of the heavy and light chain genes
bated at 47 overnight after which anti-mouse IgG Fab
were determined by the dideoxy chain termination
antibodies bound to protein G–Sepharose 4B (Sigma, St.
method by using a Sequenase version 2.0 sequencing
Louis, MO) were added and incubated with shaking at
kit (U.S. Biochemical, Gaithersburg, MD) according to the
47 for 2 hr (Harlow and Lane, 1988). The immune-precipi-
manufacturer’s directions. A primer (5*-CTAACTAGC-
tated proteins were washed three times with lysis buffer
TAGTCGCC-3 *) corresponding to pComb3 sequences
with 1% Zwittergent and once with 0.1 M Tris–HCl, pH
was used to determine the nucleotide sequence of the
8.0, 1 mM EDTA. SDS–PAGE was as described above.
variable region of the light chain. Because vector se-
quences near the 5* terminus of the heavy chain insertsPlaque-reduction neutralization test (PRNT)
existed in multiple copies in pComb 3, it was necessary
to subclone the heavy chain gene fragment into a differ-PRNT assays were performed on Vero–E6 cell mono-
layers in six-well cell culture plates with HTN and SEO ent plasmid for sequence analysis. Consequently, the
heavy chain fragment was cloned into PCRII vector (In-viruses using methods similar to those published pre-
viously (Schmaljohn et al., 1988). Briefly, the purified anti- vitrogen Corp., San Diego, CA) and the sequence was
determined by using the M13 reverse primer (Invitrogen).bodies, including IgG, papain-derived Fabs, and recombi-
nant Fabs, were standardized to 50 mg per milliliter and At least three independently selected clones were used
to determine each sequence. The variable region se-were serially diluted in twofold or fourfold increments.
Sera from hamsters challenged with HTN virus were ini- quences of light and heavy chains were analyzed by
using MacVector Sequence Analysis software (Interna-tially diluted 1:10 and then in twofold increments. The
serum dilutions were incubated with 100 PFU of HTN or tional Biotechnologies, Inc.) on a Macintosh computer.
The complementarity determining regions of 2D5 andSEO viruses at 377 for 1 to 2 hr. Virus–antibody mixtures
were applied to cell monolayers in six-well plates and HCO2 antibodies were located by comparing sequences
to those reported previously (Padlan, 1994).incubated at 377 for 1 hr in a 5% CO2 incubator and then
overlaid with EMEM containing 0.6% agarose (Seakem
Passive protection of hamstersME, FMC Corp.). After incubation at 377 for 8 days, a
second overlay identical to the first, except for the addi-
Two different protection experiments were conducted.
tion of neutral red (final concentration, 0.167 mg/ml), was
In the first study, approximately 180 to 200 mg of purified
added to the plates. The neutralizing antibody titer was
IgG from the G2-specific neutralizing MAb HCO2 or from
calculated as the reciprocal of the highest dilution re-
the nonneutralizing N-specific MAb BDO1 or recombi-
sulting in an 80% reduction of plaques in controls.
nant HCO2 Fab fragments were each passively adminis-
tered by intramuscular injection (im) to four female 8-ELISA
to 10-week-old outbred Syrian hamsters (Charles River
Breeding Laboratories, Inc., Wilmington, MA). ControlSucrose gradient-purified HTN or SEO virions (Schmal-
john et al., 1983) were diluted in PBS, pH 7.4, and 100 hamsters received PBS without antibodies. Five hours
later, the hamsters were challenged by im injection ofml was added to each well of flat-bottomed 96-well micro-
titer plates (Corning, NY) and incubated at 47 overnight. 103 PFU of HTN virus. Hamsters were bled the day before
challenge and 28 days after challenge. Blood samplesThe plates were washed three times with PBS containing
0.05% Tween-20, and 100 ml of twofold dilutions of the were examined for the presence of virus-specific anti-
bodies by using a direct immunofluorescent antibodypurified, recombinant Fabs (starting at 20 mg/ml protein
concentration) was added to the wells. The plates were assay (IFA) and HTN virus-infected Vero–E6 cells on
spot slides (Arikawa et al., 1989) and by PRNT. Animalsincubated at 377 for 1.5 hr. The plates were washed as
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were killed on Day 28 postinfection, and the lung and
kidney tissues were harvested and examined for the
presence of viral antigen by IFA as described previously
(Chu et al., 1995).
In the second study, hamsters were first infected with
103 PFU of HTN virus by im injection, and the purified
antibodies described above were passively administered
on Days 1, 2, 3, and 4 after infection (200 mg/day). The
hamsters were bled from the orbital venous sinus on
FIG. 1. Polyacrylamide gel electrophoresis of radiolabeled HTN virusDays 7, 14, and 28 after administration of antibodies. In
proteins immune-precipitated with HTN virus-specific antibodies.addition to IFA detection of viral antigen in tissues,
Lanes from left to right show products precipitated with hyperimmunenested RT–PCR was used to monitor viremia and virus
mouse ascitic fluid (polyclonal) to HTN virus (HMAF), mouse ascitic
distribution in tissues as described elsewhere (Chu et fluid containing 2D5 MAb, bacterial lysates containing recombinant
al., 1995). Briefly, total cellular RNA was extracted from 2D5 Fab, mouse ascitic fluid containing HCO2 MAb, bacterial lysate
containing recombinant HCO2 Fab, and a control bacterial lysate con-100 ml of blood or 10% lung, or kidney suspensions with
taining only the phagemid pComb 3 (C). The positions of HTN virusTrizol reagent (Gibco BRL), and HTN-specific primers
G1, G2, and N are indicated to the left of the autoradiogram.were used for RT–PCR. The outer primers used were 5*-
GGACCTGGTGCCAGTTGTGAAGC-3 * and 5*-ACCTCA-
which were secreted into the periplasmic space of theCAAACCATTGAACC-3 * (1190–1680 with respect to HTN
bacteria. Total cell lysates were prepared and ELISA wasvirus sequence), and the inner primers were 5*-GTACTG-
used to confirm that the HCO2 and 2D5 Fabs reactedATTTTAGCCTATTCTC-3 * and 5*-TGCAACGGGCAGAG-
with both anti-mouse Fab antibody and purified HTN vi-GAAAGT-3 * (1269–1625 with respect to HTN se-
rus (not shown).quences). PCR was performed for 35 cycles for 30 sec
To determine if the Fabs retained the ability to recog-at 947, 30 sec at 507, and 2 min at 727.
nize HTN virus proteins, the clarified supernatants from
bacterial lysates containing Fab fragments were used toRESULTS
immune-precipitate radiolabeled HTN virus proteins. The
Expression and characterization of Fab fragments HCO2 and 2D5 Fabs were able to recognize and precipi-
tate HTN virus G2 and G1, respectively (Fig. 1).We PCR-amplified and cloned into pComb3 the heavy
chain Fd region and complete light chain antibody genes
Sequence analysis of the heavy and light chainfrom two mouse hybridomas secreting neutralizing anti-
antibody genesbodies to HTN virus G2 (clone HCO2) or G1 (clone 2D5).
Expression of both genes was controlled by the E. coli To examine the diversity in the heavy and light chain
antibody genes of the HCO2 and 2D5 Fabs, the nucleo-lac promoter/operator (Barbas et al., 1991). The heavy
chain was expressed as a fusion protein with phage tide sequences encoding the variable domains of heavy
and light chains from 2D5 and HCO2 IgG were deter-coat protein III (cpIII), and the light chain was expressed
independently. A pelB leader sequence preceding both mined and compared. These sequences were aligned
to those in GenBank by using the Wisconsin Sequencegenes directed the expression products to the bacterial
periplasmic space where assembly into Fab fragments Analysis Package software. Such alignment indicated
that the sequences belonged to the mouse immunoglob-occurred. Because of the cpIII portion of the heavy chain
fusion protein, the Fabs remained tethered to the inner ulin family IgG l chain and k chain, but were not identical
to any other sequences deposited in GenBank. The nu-bacterial membrane. Because the Fab genes were ex-
tracted from the hybridoma cells, it was not necessary cleotide sequences determined for the HCO2 and 2D5
clones were deposited in GenBank under Accessionto use phage display techniques or panning on specific
antigen to select for recombinant clones. Instead, to iden- Nos. L46808, L46809, L46813, and L46814. Alignment of
the deduced amino acid sequences of the 2D5 and HCO2tify specific bacterial clones expressing the Fabs of inter-
est, we performed colony-screening assays on the bacte- variable regions revealed framework regions typical of
other mouse immunoglobulin frameworks (Padlan, 1994)ria transformed with the pComb3 vectors by using gradi-
ent-purified HTN virus antigen as described under that were highly conserved between the HCO2 and 2D5
heavy chains (88.5% amino acid sequence identity) andMaterials and Methods. Most, but not all, colonies ex-
pressed antibodies capable of recognizing HTN virus relatively conserved between the HCO2 and 2D5 light
chains (65% amino acid sequence identity). The hyper-(data not shown).
After selecting clones expressing HTN virus-specific variable, complementarity determining regions (CDR1–
CDR3) of 2D5 and HCO2, in contrast, had little homologyFabs, we recovered phagemid DNA and removed the
gene III fragment to allow production of soluble Fabs, (Fig. 2).
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FIG. 2. Deduced protein sequences of heavy and light chain V-genes of MAbs 2D5 and HCO2. FR, framework region; CDR, complementarity
determining region. Complete sequences are available in GenBank under Accession Nos. HCO2 VH, L46808; 2D5 VH, L46809; HCO2 VL, L46813;
2D5 VL, L46814.
Purification and assay of recombinant Fabs the MAbs and Fabs (i.e., equal amounts of MAb and Fab
had antigen-binding valencies of 2 and 3 per 150 kDa,
For subsequent experiments, it was necessary to pu-
respectively), we could not directly compare the avidities
rify and assay the recombinant Fabs. Consequently, Fab
of the MAbs and Fabs; however, a relative comparison
fragments were purified from bacterial lysates, and IgG
of binding avidity (defined as the amount of antibody
MAbs were purified from mouse ascitic fluids by affinity
required to yield an absorbance of about 0.4–0.5 at OD405chromatography. Fabs were also prepared by papain di-
with HTN virus antigen) yielded values of 0.02 mg for the
gestion of MAbs and purified by affinity chromatography.
HCO2 Fab, 0.04 mg for the HCO2 MAb, 0.16 mg for 2D5
The purity of the various antibodies and antibody frag-
Fab, and 0.31 mg for the 2D5 MAb (Fig. 4).
ments was established by gel electrophoresis. Purified
IgG yielded two bands with the expected apparent mo-
Neutralization of infectious virus with the recombinantlecular masses of approximately 50 and 23 kDa. The
Fabsapparent molecular weights of the heavy chain Fd region
and the light chain of the papain-derived Fabs were ap- PRNT of HTN and SEO viruses were performed with
proximately 25 and 23 kDa, respectively. Because both dilutions of purified MAbs, Fabs resulting from papain
the heavy and the light chain gene expression products
were approximately the same size (23 kDa) (i.e., the
heavy chain product was slightly smaller than that of
papain-derived Fabs), the products were not resolved
from one another by this method (Fig. 3).
Antigen-binding specificity of the recombinant Fabs
Previously, we demonstrated that the G2-specific MAb
HCO2 reacted with both HTN and SEO virus antigens in
ELISA, but that the G1-specific MAb 2D5 reacted only
with HTN virus antigen (Arikawa et al., 1989). To deter-
mine if the recombinant Fabs retained these specificities,
FIG. 3. Coomassie blue-stained polyacrylamide gel. Lane 1, HCO2indirect ELISA with purified HTN and SEO virions were
IgG purified from mouse ascitic fluid; lane 2, Fabs resulting from papainperformed. Concentrations of purified Fabs from 0.08 to
digestion of HCO2 IgG; lanes 3 and 4, respectively, recombinant HCO22.0 mg/ml were tested. As with the authentic MAbs, re-
and 2D5 Fabs purified from bacterial lysates; lanes 5 and 6, unpurified
combinant HCO2 Fab reacted with both HTN and SEO bacterial lysates containing recombinant HCO2 and 2D5, respectively.
virus antigens, while 2D5 Fab reacted only with HTN The positions of stained molecular weight size markers (not shown)
are indicated to the left of lane 1.antigen (Fig. 4). Because of valency differences between
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lenged with HTN virus. To more clearly define the amount
of the HCO2 IgG MAb required for protection from HTN
virus challenge we compared the circulating neutralizing
antibody titers achieved 5 hr after transfer of 0.2 ml of
unpurified mouse ascitic fluid to those attained after
transfer of 50 or 360 mg of IgG purified from the ascitic
fluid. We also checked viral antigen deposition in the
hamsters’ lungs and kidneys 21 days after challenge with
HTN virus. We found that transfer of 0.2 ml of unpurified
ascitic fluid or 50 mg of purified IgG resulted in neutraliz-
ing antibody titers of 10 in three of four hamsters and
10 in one of four hamsters in each group (Table 1). All
hamsters with neutralizing titers of at least 10 did not
display HTN virus antigen in their lungs after challenge
and did not develop detectable postchallenge neutraliz-
ing antibodies, indicating that they were protected from
infection (Table 1). The two hamsters with neutralizing
titers of 10 both had IFA-detectable antigen in their
lungs and developed neutralizing antibodies after chal-
lenge. Of the four hamsters that received 360 mg of the
HCO2 IgG, one animal with a neutralizing antibody titer
of 10 displayed very weak fluorescence in lung samples
(Table 1). None of these hamsters had detectable post-
challenge neutralizing antibodies (Table 1). Thus, a pre-
challenge neutralization titer of at least 10 was deter-
FIG. 4. Specificity of binding of 2D5 and HCO2 Fabs to HTN and
mined to protect hamsters from infection with HTN virus.SEO virus antigen. ELISA was performed with dilutions of purified,
recombinant 2D5 and HCO2 Fabs and sucrose gradient-purified HTN
or SEO virions. ELISA results are presented as the amount of antibody
needed to achieve OD405 nm readings listed on the Y axis.
digestion, or recombinant Fabs. HTN virus could be neu-
tralized by all of the antibodies and antibody fragments,
but only HCO2 antibodies or antibody fragments were
able to neutralize SEO virus. We found that approximately
0.63 mg of the recombinant HCO2 Fab resulted in an 80%
reduction in plaques, whereas approximately 2.5 mg of
2D5 Fab was required. Again, without regard to valency
differences, these amounts were very similar to those of
the authentic MAbs and Fabs required for neutralization
(Fig. 5).
Passive protection of hamsters
An animal model that mimics the symptoms of HFRS
has not been reported, but a hamster model of protection
has been used that is based on the finding that viral
antigen can be detected in the lungs of infected hamsters
(Schmaljohn et al., 1990). This model was used pre-
viously to demonstrate that passively transferred neu-
tralizing MAbs to HTN virus G1 or G2 can protect ham-
FIG. 5. Plaque-reduction neutralization test (PRNT) with HTN andsters from infection with HTN virus (Schmaljohn et al.,
SEO viruses. After standardization to 50 mg per milliliter, twofold dilu-1990). In that study, 0.2 ml of nonpurified mouse ascitic
tions of purified 2D5 and HCO2 MAbs, Fabs resulting from papain
fluid containing neutralizing or nonneutralizing MAbs to digestion (P-Fab) or recombinant Fabs (R-Fab), were assayed by PRNT.
HTN virus G1 or G2 was administered by the im route The X axis indicates amounts of antibody required to achieve % neutral-
ization (Y axis) of approximately 100 plaques.to hamsters and the hamsters were subsequently chal-
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TABLE 1 To determine if passive transfer of Fabs could moder-
ate a prior infection with HTN virus, hamsters were firstPassive Protection of Hamsters with a Neutralizing
challenged with HTN virus and then were treated withG2-Specific MAb to HTN Virus
HCO2 MAb, Fab, or a control MAb on Days 1 to 4 after
PRNT antibodya challenge. Viremia was monitored 7 days after challenge
Antigenb by RT–PCR, and HTN-specific antibody was detected by
Inoculuma and hamster Pre Post in lungs
IFA and PRNT 21 days after challenge. The presence of
virus in the hamsters’ lungs was also checked 21 daysHCO2 ascitic fluid (0.2 ml)
1 10 40 /// after challenge by IFA and by RT–PCR. Only the ham-
2 10 10 0 sters that received HCO2 IgG did not display viremia,
3 10 10 0 did not develop antibodies to HTN virus, and had no
4 10 10 0
detectable virus in their lungs (Table 3).
HCO2 IgG (50 mg)
1 10 10 /
DISCUSSION2 10 10 0
3 10 10 0
Previous studies demonstrated that MAbs 2D5 and4 10 10 0
HCO2, which respectively react with the G1 or G2 enve-
HCO2 IgG (360 mg)
1 10 10 0
2 40 10 0
TABLE 23 40 10 0
4 10 10 { Passive Protection of Hamsters with a Neutralizing
G2-Specific MAb to HTN Virus
a Antibody titers were measured by PRNT 5 hr after antibodies were
transferred (pre) and 21 days after challenge (post) and are expressed PRNT antibodya Antigenb
as the reciprocal of the highest dilution neutralizing 80% of plaques in Inoculuma
controls. and hamster Pre Post Lungs Kidneys
b Viral antigen in lungs and kidneys was monitored by IFA 21 days
after challenge,////,///,//, and/ correspond to approximately HCO2 IgG
100, 75, 50, and 25% fluorescent cells per field of assay. { indicates 1 40 10 0 0
very weak fluorescence in only a few cells. 2 40 10 0 0
3 10 10 0 0
4 40 10 0 0
We next compared the ability of authentic HCO2 MAb
HCO2 Fab
and recombinant HCO2 Fabs to protect hamsters from 1 10 40 //// ////
challenge. Based on the results presented in Table 1, a 2 10 40 //// ////
3 10 40 //// ////dose of 200 mg of HCO2 IgG was selected in order to
4 10 160 //// ////achieve circulating neutralizing antibody titers of at least
5 20 40 //// ////10. An equivalent quantity (approximately 200 mg) of puri-
BDO1 IgGfied, E. coli-expressed HCO2 Fab and a control, nonneu-
1 10 160 //// ////tralizing antibody were injected into hamsters, and the
2 10 40 //// ////hamsters were challenged 5 hr later with HTN virus. As
3 10 160 //// ////
before, immediately before challenge, the hamsters were 4 10 160 //// ////
bled and the neutralizing antibody titers to HTN virus 5 10 40 //// ////
were determined. All of the hamsters receiving HCO2
Mock
IgG and four of five hamsters receiving HCO2 Fab had 1 10 160 //// ////
neutralizing antibody titers of at least 10 before challenge 2 10 320 //// ////
3 10 160 //// ////(Table 2). The hamsters that received a control, nucleo-
4 10 320 //// ////capsid-specific MAb (BDO1) and hamsters that received
5 10 160 //// ////a mock preparation did not have detectable neutralizing
antibodies before challenge. Twenty-one days after chal- Note. The concentrations of antibodies were all 180 to 200 mg, given
lenge, only the hamsters given authentic HCO2 MAb had im.
a Antibody titers were determined by PRNT 5 hr after antibodies wereno PRNT-detectable antibodies to HTN virus and these
transferred (pre) and 21 days after challenge (post) and are expressedanimals were also the only ones that had no detectable
as the reciprocal of the highest dilution neutralizing 80% of plaques inHTN virus antigen in their lungs or kidneys (Table 2).
controls.
These data indicate that the passively transferred HCO2 b Viral antigen in lungs and kidneys was observed by IFA 21 days
Fabs did not prevent infection with HTN virus under the after challenge. //// indicates fluorescence in 100% of cells exam-
ined.experimental conditions used.
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TABLE 3
Postchallenge Viremia, Antibody, and Viral Antigen and RNA in Hamsters Receiving Passively Transferred Antibodies
on Days 1, 2, 3, and 4 after Infection with Hantaan Virus
aRNA or antigen
Viremia Antibodya Lungs Kidneys
Inoculum
and hamster 7 days PI IFA PRNT IFA PCR IFA PCR
HCO2 Fab
1 / 160 40 //// / //// /
2 / ¢640 40 //// / //// 0
3 / ¢640 40 //// / //// /
4 / ¢640 40 //// / //// /
HCO2 IgG
1 0 10 10 0 0 0 0
2 0 10 10 0 0 0 0
3 0 10 10 0 0 0 0
4 0 10 10 0 0 0 0
BDO1 IgG
1 / ¢640 160 //// / //// /
2 0 ¢640 40 // / // 0
3 / 160 40 / / / /
4 / 40 10 0 / 0 0
Mock
1 0 ¢640 40 //// / //// /
2 / 160 40 //// / //// /
3 / 160 40 //// / //// /
4 / ¢640 40 //// / //// /
Note. The concentrations of antibodies were all 180 to 200 mg, given im. For IFA results, ////, ///, //, and / correspond to approximately
100, 75, 50, and 25% fluorescent cells per field of assay.
a Serum antibody titers and antigen and RNA in lungs and kidneys were measured 21 days after infection.
lope glycoproteins of HTN virus, can neutralize virus in perturb entry of virus into host cell and/or its subsequent
uncoating (Dimmock, 1995).vitro and can passively protect hamsters from HTN virus
infection (Arikawa et al., 1989; Schmaljohn et al., 1990). To compare the protective or therapeutic properties of
the HCO2 Fab to those of the HCO2 MAb, we passivelyThe G2 protein of HTN virus is more highly conserved
among differing serotypes of hantaviruses than is the G1 transferred antibodies to hamsters either before or after
challenge with HTN virus. Hamsters that received theprotein (Chu et al., 1994), and the HTN G2-specific MAb
HCO2 reacts with both HTN and SEO viruses, while the complete HCO2 MAb before challenge with HTN virus
did not develop viremia and did not display viral antigenG1-specific MAb 2D5 reacts only with HTN virus. In this
study, we examined Fabs expressed from cloned heavy in their lungs or kidneys, but the hamsters treated simi-
larly with the recombinant Fab became viremic and dis-and light chain antibody genes of hybridomas secreting
2D5 and HCO2. We determined that the recombinant played viral antigen in their organs. Because Fabs are
expected to have a shorter half-life than MAbs (4 to 6proteins had the same antigenic specificities and neu-
tralizing properties for HTN and SEO viruses as the par- days for IgG2b MAb as compared to less than 12 hr
for Fabs) (Vieira and Rajewsky, 1988; Spiegelberg andent MAbs. Because the recombinant Fabs were monova-
lent, these results suggest that neither cross-linking of Wiegle, 1965; Sharkey et al., 1991), it is possible that the
5 hr between transfer of the antibodies and challengeviral particles nor cross-linking of envelope glycoproteins
on the viral surface was required for antigen binding or was too long for the Fabs, as reflected by the circulating
neutralizing antibody titers which were as much as four-neutralization in vitro. Although we did not determine the
actual mechanism of neutralization by the Fabs, possibili- fold lower (1:10 compared to 1:40) in hamsters that re-
ceived Fabs compared to those that received MAbs.ties include prevention of adsorption of virus to host cell
receptors, inhibition of fusion of the viral envelope to the However, we do not think that insufficient quantities of
Fabs was the only reason for the absence of protectionhost plasma membrane, or alteration of the hantaviral
envelope glycoproteins (conformational changes) that by the Fabs, because our studies indicated that even
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Antoniadis, A., LeDuc, J., Acritidis, N., Alexiou, D., Kyparissi, A., and1:10 neutralizing antibody titers of the MAbs completely
Saviolakis, G. (1989). Characteristics of passive immunity againstprotected most hamsters from challenge.
hantavirus infection in rats. Arch. Virol. 105, 235–246.
The results of our passive transfer studies in which Arikawa, J., Schmaljohn, A. L., Dalrymple, J. M., and Schmaljojhn,
MAbs or Fabs were transferred each of 4 days after C. S. (1989). Characterization of Hantaan virus envelope glycoprotein
antigenic determinants defined by monoclonal antibodies. J. Gen.challenge yielded similar results. That is, only the ham-
Virol. 70, 615–624.sters that received the HCO2 MAb did not show evidence
Arikawa, J., Yao, J., Yoshimatsu, K., Takashima, I., and Hashimoto, N.of HTN virus infection. In these studies, the half-life of
(1992). Protective role of antigenic sites on the envelope protein of
the antibody would be less important. Hantaan virus defined by monoclonal antibodies. Arch. Virol. 126,
Our finding that neutralization was not necessarily suf- 271–281.
Avsic-Zupanc, T., Poljak, M., Furlan, P., Kaps, R., Xiao, S. Y., and Leduc,ficient for protection is similar to results obtained with
J. W. (1994). Isolation of a strain of a Hantaan virus from a fatal caseneutralizing (Fab*)2 fragments to the flavivirus yellow fe-
of hemorrhagic fever with renal syndrome in Slovenia. Am. J. Trop.ver virus (Schlesinger et al., 1994) and to the arenavirus
Med. Hyg. 51, 393–400.
LCM virus (Baldridge and Buchmeier, 1992). Among the Avsic-Zupanc, T., Xiao, S. Y., Stojanovic, R., Gligic, A., van der Groen,
possible explanations for the inability of those molecules G., and LeDuc, J. W. (1992). Characterization of Dobrava virus: A
Hantavirus from Slovenia, Yugoslavia. J. Med. Virol. 38, 132–137.and our Fabs to protect from challenge despite their
Baldridge, J. R., and Buchmeier, M. J. (1992). Mechanisms of antibody-ability to neutralize virus in vitro is that in the absence
mediated protection against lymphocytic choriomeningitis virus in-of an Fc region, there is a coincident inability to partici-
fection: Mother-to-baby transfer of humoral protection. J. Virol. 66,
pate in several humoral and cellular immune functions 4252–4257.
that are potentially important for virus clearance. For ex- Barbas, C., III, Crowe, J., Jr., Cababa, D., Jones, T. M., Zebedee, S. L.,
Murphy, B. R., Chanock, R. M., and Burton, D. R. (1992). Humanample, neither opsonization nor activation of complement
monoclonal Fab fragments derived from a combinatorial library bindvia the classical pathway can occur if the Fc region is
to respiratory syncytial virus F glycoprotein and neutralize infectivity.not present. Although either or both of these might be
Proc. Natl. Acad. Sci. USA 89, 10164–10168.
involved in clearance of virus from infected hosts, com- Barbas, C., III, Kang, A. S., Lerner, R. A., and Benkovic, S. J. (1991).
plement is clearly not critical for neutralization of HTN Assembly of combinatorial antibody libraries on phage surfaces: The
gene III site. Proc. Natl. Acad. Sci. USA 88, 7978–7982.virus in vitro, as indicated by results obtained with heat-
Brummer-Korvenkontio, M., Vaheri, A., von Bonsdorff, C.-H., Vuorimies,inactivated sera (Lee and Dalrymple, 1989) and by the
J., Manni, T., Penttinen, K., Oker-Blom, N., and La¨hdevirta, J. (1980).results presented in this report. The absence of the Fc
Nephropathia epidemica: Detection of antigen in bank voles and
region also precludes antibody-dependent cellular cyto- serologic diagnosis of human infection. J. Infect. Dis. 141, 131–134.
toxicity and activation of natural killer cells (Lynch and Burton, D. R., Barbas, C., III, Persson, M. A., Koenig, S., Chanock,
R. M., and Lerner, R. A. (1991). A large array of human monoclonalSandor, 1990). It is not known if either of these functions
antibodies to type 1 human immunodeficiency virus from combinato-is crucial in the development of immunity to HTN virus.
rial libraries of asymptomatic seropositive individuals. Proc. Natl.Obviously, further studies are needed to determine the
Acad. Sci. USA 88, 10134–10137.
mechanism(s) of antibody-mediated protection. Caton, A. J., and Koprowski, H. (1990). Influenza virus hemagglutinin-
In conclusion, this study demonstrates for the first time specific antibodies isolated from a combinatorial expression library
are closely related to the immune response of the donor [publishedthe possibility of using cloned antibody genes to gener-
erratum appears in Proc. Natl. Acad. Sci. USA, 1991, 88, 1590]. Proc.ate neutralizing monoclonal antibody fragments to HTN
Natl. Acad. Sci. USA 87, 6450–6454.virus. It also provides evidence that in vitro neutralization
Cheung, S. C., Dietzchold, B., Koprowski, H., Notking, A. L., and Rando,
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Finally, our results suggest that additional studies are coli neutralizes rabies virus. J. Virol. 66, 6714–6720.
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